AMN Healthcare (AMN) PT Raised to $86 at BMO Capital
BMO Capital analyst Jeffrey Silber raised the price target on AMN Healthcare (NYSE: AMN) to $86.00 (from $81.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Australian Pharma (API:AU) PT Raised to AUD1.55 at Credit Suisse
- China Yuhua Education Corp. (6169:HK) PT Lowered to HK$6.70 at CLSA
- Sigma Healthcare Ltd. (SIG:AU) PT Lowered to AUD0.70 at Credit Suisse
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!